SciELO - Scientific Electronic Library Online

 
vol.55 issue1Methotrexate as inducer of proinflammatory cytokines by epithelial cellsPrevalence of β-lactamase CTX-M-15 in phylogenetic groups of uropathogenic Escherichia coli isolated from patients in the community of Merida, Venezuela author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Investigación Clínica

Print version ISSN 0535-5133

Abstract

RODRIGUEZ, Rosalva et al. Genetic variations of b-MYH7 in Venezuelan patients with hypertrophic cardiomyopathy. Invest. clín [online]. 2014, vol.55, n.1, pp.23-31. ISSN 0535-5133.

Hypertrophic cardiomyopathy (HCM) is a cardiac disease, characterized by marked hypertrophy and genetic variability. HCM has been associated with sarcomere protein mutations, being cardiac b-myosin (coded by the MYH7 gene) and myosin binding protein C (coded by the MYBPC3 gene) the most frequently affected proteins. As in Venezuela only the clinical analysis are performed in HCM patients, we decided to search for genetic variations in the MYH7 gene. Coding regions, including the junction exon-intron of the MYH7 gene, were studied in 58 HCM patients, whose samples were collected at the ASCARDIO Hospital (Barquisimeto, Lara state, Venezuela) and 106 control subjects from the ASCARDIO Hospital and the IVIC (Barquisimeto Lara state and Miranda, Venezuela, respectively). The blood samples were analyzed by genomic DNA isolation, followed by polymerase chain reaction and sequence analysis. The screening of the MYH7 gene revealed eight already reported polymorphic variants, as well as two intronic variations in these HCM patients. Neither any missense mutations nor other pathological mutations in the MYH7 gene were found in the HCM patients.

Keywords : MYH7; sudden death; hypertrophy; cardiomyopathy; mutation.

        · abstract in Spanish     · text in English     · English ( pdf )